术中诊断胸膜播散的肺腺癌:切除主肿瘤是否有利于预后
本研究回顾性纳入2006年1月至2014年12月术中意外诊断胸膜播散的肺腺癌患者43例,比较切除主肿瘤与仅胸膜活检的生存差异。主肿瘤切除组30例,仅活检组13例;主肿瘤切除组无进展生存和总生存均优于仅活检组,亚肺叶切除与肺叶切除之间无显著生存差异。
要点
- 主肿瘤切除组3年无进展生存44.5% vs 仅活检组0%(P = .009)。
- 主肿瘤切除组3年总生存82.9% vs 仅活检组38.5%(P = .013)。
- 主肿瘤切除组亚肺叶切除与肺叶切除之间无显著生存差异。
核心结论
- 主肿瘤及可见胸膜结节切除可改善术中诊断胸膜播散的肺腺癌患者的无进展生存和总生存。
- 需要进一步随机试验来确定主肿瘤切除在这些患者中的作用。
研究设计与样本
- 回顾性研究,使用前瞻性收集的肺癌数据库,纳入2006年1月至2014年12月术中意外诊断胸膜播散的肺腺癌患者43例。
- 由每位外科医生决定行主肿瘤切除或仅胸膜活检;主肿瘤切除组30例,仅胸膜活检组(open-close组)13例。
主要发现
- 仅活检组临床T分期高于主肿瘤切除组(P = .02)。
- 主肿瘤切除组手术时间长于仅活检组(均值141.8 vs 80.3分钟)。
- 围手术期其他参数无其他统计学显著差异。
- 手术方式是唯一有统计学意义的预后因素。
- 主肿瘤切除组无进展生存(3年生存率44.5% vs 0%;P = .009)和总生存(3年生存率82.9% vs 38.5%;P = .013)均优于仅活检组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether main tumor resection improves survival compared with pleural biopsy alone in patients with lung adenocarcinoma with intraoperatively diagnosed pleural seeding. METHODS: Forty-three patients with lung adenocarcinoma with pleural seeding diagnosed unexpectedly during surgery performed between January 2006 and December 2014 were included in this retrospective study using a prospectively collected lung cancer database. Each surgeon decided whether to perform main tumor resection or pleural biopsy alone. RESULTS: Main tumor and visible pleural nodule resection was performed in 30 patients (tumor resection group). The remaining 13 patients underwent pleural nodule biopsy alone (open-close group). The clinical T stage was higher in the open-close group than in the tumor resection group (P = .02). The tumor resection group had longer operative times compared with the open-close group (mean, 141.8 vs 80.3 minutes). There were no other statistically significant differences in perioperative parameters. The surgical method was the sole statistically significant prognostic factor. Patients in the tumor resection group had better progression-free survival (3-year survival: 44.5% vs 0%; P = .009) and overall survival (3-year survival: 82.9% vs 38.5%; P = .013) than did the open-close group. There was no significant survival difference between sublobar resection and lobectomy for the main tumor resection. CONCLUSIONS: Our study demonstrated improved progression-free and overall survival after main tumor and visible pleural nodule resection in patients with lung adenocarcinoma with intraoperatively diagnosed pleural seeding. Further randomized trials are needed to define the role of main tumor resection in these patients.
引用
- Li C, Kuo SW, Hsu HH, et al. Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis? J Thorac Cardiovasc Surg. 2017. PMID: 29254636. doi:10.1016/j.jtcvs.2017.09.162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。